메뉴 건너뛰기




Volumn 10, Issue 4, 2015, Pages 577-585

Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: What we have learned

Author keywords

Central lesion; Dose volume constraints; Early stage lung cancer; SABR; SBRT; Survival; Toxicity

Indexed keywords

ABLATION THERAPY; BRACHIAL PLEXUS; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; DRUG DOSE REGIMEN; EARLY CANCER; ESOPHAGUS; HUMAN; IMAGE GUIDED RADIOTHERAPY; NON SMALL CELL LUNG CANCER; PHRENIC NERVE; PRESCRIPTION; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; STEREOTACTIC BODY RADIATION THERAPY; TRACHEOBRONCHIAL TREE; TUMOR VOLUME; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; LUNG NEOPLASMS; PATHOLOGY; PROCEDURES; RADIOSURGERY;

EID: 84938290741     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000453     Document Type: Review
Times cited : (133)

References (50)
  • 2
    • 77949520655 scopus 로고    scopus 로고
    • Stereotactic body radiation therapy for inoperable early stage lung cancer
    • Timmerman R, Paulus R, Galvin J, Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010 303 1070 1076
    • (2010) JAMA , vol.303 , pp. 1070-1076
    • Timmerman, R.1    Paulus, R.2    Galvin, J.3
  • 3
    • 84865838613 scopus 로고    scopus 로고
    • Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage i non-small cell lung cancer
    • Chang JY, Liu H, Balter P, Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer. Radiat Oncol 2012 7 152
    • (2012) Radiat Oncol , vol.7 , pp. 152
    • Chang, J.Y.1    Liu, H.2    Balter, P.3
  • 4
    • 84855843127 scopus 로고    scopus 로고
    • Stereotactic body radiotherapy for medically inoperable lung cancer: Prospective, single-center study of 108 consecutive patients
    • Taremi M, Hope A, Dahele M, Stereotactic body radiotherapy for medically inoperable lung cancer: Prospective, single-center study of 108 consecutive patients. Int J Radiat Oncol Biol Phys 2012 82 967 973
    • (2012) Int J Radiat Oncol Biol Phys , vol.82 , pp. 967-973
    • Taremi, M.1    Hope, A.2    Dahele, M.3
  • 5
    • 84919667191 scopus 로고    scopus 로고
    • Lobectomy, sublobar resection, and stereotactic radiation for stage 1 non-small cell lung cancers in the elderly
    • Shirvani SM, Jiang J, Chang JY, Lobectomy, sublobar resection, and stereotactic radiation for stage 1 non-small cell lung cancers in the elderly. JAMA Surg 2014 149 1244 1253
    • (2014) JAMA Surg , vol.149 , pp. 1244-1253
    • Shirvani, S.M.1    Jiang, J.2    Chang, J.Y.3
  • 6
    • 84878448602 scopus 로고    scopus 로고
    • Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (sabr) or lobectomy by video-Assisted thoracoscopic surgery (vats): Outcomes of a propensity score-matched analysis
    • Verstegen NE, Oosterhuis JW, Palma DA, Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-Assisted thoracoscopic surgery (VATS): Outcomes of a propensity score-matched analysis. Ann Oncol 2013 24 1543 1548
    • (2013) Ann Oncol , vol.24 , pp. 1543-1548
    • Verstegen, N.E.1    Oosterhuis, J.W.2    Palma, D.A.3
  • 7
    • 79951864385 scopus 로고    scopus 로고
    • Impact of introducing stereotactic lung radiotherapy for elderly patients with stage i non-small-cell lung cancer: A population-based time-Trend analysis
    • Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman BJ, Senan S, Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: A population-based time-Trend analysis. J Clin Oncol 2010 28 5153 5159
    • (2010) J Clin Oncol , vol.28 , pp. 5153-5159
    • Palma, D.1    Visser, O.2    Lagerwaard, F.J.3    Belderbos, J.4    Slotman, B.J.5    Senan, S.6
  • 8
    • 84883599546 scopus 로고    scopus 로고
    • Stereotactic ablative radiotherapy: A potentially curable approach to early stage multiple primary lung cancer
    • Chang JY, Liu YH, Zhu Z, Stereotactic ablative radiotherapy: A potentially curable approach to early stage multiple primary lung cancer. Cancer 2013 119 3402 3410
    • (2013) Cancer , vol.119 , pp. 3402-3410
    • Chang, J.Y.1    Liu, Y.H.2    Zhu, Z.3
  • 9
    • 84871828017 scopus 로고    scopus 로고
    • Stereotactic body radiotherapy for oligometastases
    • Tree AC, Khoo VS, Eeles RA, Stereotactic body radiotherapy for oligometastases. Lancet Oncol 2013 14 e28 e37
    • (2013) Lancet Oncol , vol.14 , pp. e28-e37
    • Tree, A.C.1    Khoo, V.S.2    Eeles, R.A.3
  • 10
    • 84909581571 scopus 로고    scopus 로고
    • The oligometastatic state-separating truth from wishful thinking
    • Palma DA, Salama JK, Lo SS, The oligometastatic state-separating truth from wishful thinking. Nat Rev Clin Oncol 2014 11 549 557
    • (2014) Nat Rev Clin Oncol , vol.11 , pp. 549-557
    • Palma, D.A.1    Salama, J.K.2    Lo, S.S.3
  • 11
    • 78549236469 scopus 로고    scopus 로고
    • Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation
    • Kelly P, Balter PA, Rebueno N, Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation. Int J Radiat Oncol Biol Phys 2010 78 1387 1393
    • (2010) Int J Radiat Oncol Biol Phys , vol.78 , pp. 1387-1393
    • Kelly, P.1    Balter, P.A.2    Rebueno, N.3
  • 12
    • 33750612133 scopus 로고    scopus 로고
    • Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer
    • Timmerman R, McGarry R, Yiannoutsos C, Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006 24 4833 4839
    • (2006) J Clin Oncol , vol.24 , pp. 4833-4839
    • Timmerman, R.1    McGarry, R.2    Yiannoutsos, C.3
  • 13
    • 54049131325 scopus 로고    scopus 로고
    • Stereotactic body radiation therapy in centrally and superiorly located stage i or isolated recurrent non-small-cell lung cancer
    • Chang JY, Balter PA, Dong L, Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008 72 967 971
    • (2008) Int J Radiat Oncol Biol Phys , vol.72 , pp. 967-971
    • Chang, J.Y.1    Balter, P.A.2    Dong, L.3
  • 14
  • 15
    • 68949210483 scopus 로고    scopus 로고
    • Fractionated stereotactic body radiation therapy for medically inoperable stage i lung cancer adjacent to central large bronchus
    • Song SY, Choi W, Shin SS, Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus. Lung Cancer 2009 66 89 93
    • (2009) Lung Cancer , vol.66 , pp. 89-93
    • Song, S.Y.1    Choi, W.2    Shin, S.S.3
  • 16
    • 81755179379 scopus 로고    scopus 로고
    • Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer
    • Haasbeek CJ, Lagerwaard FJ, Slotman BJ, Senan S, Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer. J Thorac Oncol 2011 6 2036 2043
    • (2011) J Thorac Oncol , vol.6 , pp. 2036-2043
    • Haasbeek, C.J.1    Lagerwaard, F.J.2    Slotman, B.J.3    Senan, S.4
  • 18
    • 84857920119 scopus 로고    scopus 로고
    • Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors
    • Nuyttens JJ, van der Voort van Zyp NC, Praag J, Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors. Radiother Oncol 2012 102 383 387
    • (2012) Radiother Oncol , vol.102 , pp. 383-387
    • Nuyttens, J.J.1    Van Der Voort Van Zyp, N.C.2    Praag, J.3
  • 19
    • 33746841847 scopus 로고    scopus 로고
    • Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II non-small-cell lung cancer
    • Xia T, Li H, Sun Q, Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006 66 117 125
    • (2006) Int J Radiat Oncol Biol Phys , vol.66 , pp. 117-125
    • Xia, T.1    Li, H.2    Sun, Q.3
  • 20
    • 84897867716 scopus 로고    scopus 로고
    • Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: How to fly in a "no fly zone"
    • Chang JY, Li QQ, Xu QY, Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: How to fly in a "no fly zone". Int J Radiat Oncol Biol Phys 2014 88 1120 1128
    • (2014) Int J Radiat Oncol Biol Phys , vol.88 , pp. 1120-1128
    • Chang, J.Y.1    Li, Q.Q.2    Xu, Q.Y.3
  • 21
    • 84911001503 scopus 로고    scopus 로고
    • Stereotactic ablative radiotherapy (sabr) using 70 gy in 10 fractions for non-small cell lung cancer: Exploration of clinical indications
    • Li QQ, Swanick CW, Allen PK, Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: Exploration of clinical indications. Radiother Oncol 2014 112 256 261
    • (2014) Radiother Oncol , vol.112 , pp. 256-261
    • Li, Q.Q.1    Swanick, C.W.2    Allen, P.K.3
  • 22
    • 84920144171 scopus 로고    scopus 로고
    • Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiotherapy
    • Modh A, Rimner A, Williams E, Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2014 1 1168 1176
    • (2014) Int J Radiat Oncol Biol Phys , vol.1 , pp. 1168-1176
    • Modh, A.1    Rimner, A.2    Williams, E.3
  • 23
    • 84938293273 scopus 로고    scopus 로고
    • Toxicity after central versus peripheral lung stereotactic body radiotherapy (sbrt): A propensity score matched-pair analysis
    • October 18, 2014 [Epub ahead of print
    • Mangona VS, Aneese AM, Marina O, Toxicity after central versus peripheral lung stereotactic body radiotherapy (SBRT): A propensity score matched-pair analysis. Int J Radiat Oncol Biol Phys. October 18, 2014 [Epub ahead of print
    • Int J Radiat Oncol Biol Phys
    • Mangona, V.S.1    Aneese, A.M.2    Marina, O.3
  • 24
    • 68049136288 scopus 로고    scopus 로고
    • Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study
    • Fakiris AJ, McGarry RC, Yiannoutsos CT, Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009 75 677 682
    • (2009) Int J Radiat Oncol Biol Phys , vol.75 , pp. 677-682
    • Fakiris, A.J.1    McGarry, R.C.2    Yiannoutsos, C.T.3
  • 25
    • 84905918611 scopus 로고    scopus 로고
    • Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: Risk factors for late toxicity
    • Stephans KL, Djemil T, Diaconu C, Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: Risk factors for late toxicity. Int J Radiat Oncol Biol Phys 2014 90 197 202
    • (2014) Int J Radiat Oncol Biol Phys , vol.90 , pp. 197-202
    • Stephans, K.L.1    Djemil, T.2    Diaconu, C.3
  • 26
    • 84906261152 scopus 로고    scopus 로고
    • Toxicities of organs at risk in the mediastinal and hilar regions following stereotactic body radiotherapy for centrally located lung tumors
    • Nishimura S, Takeda A, Sanuki N, Toxicities of organs at risk in the mediastinal and hilar regions following stereotactic body radiotherapy for centrally located lung tumors. J Thorac Oncol 2014 9 1370 1376
    • (2014) J Thorac Oncol , vol.9 , pp. 1370-1376
    • Nishimura, S.1    Takeda, A.2    Sanuki, N.3
  • 27
    • 84862169679 scopus 로고    scopus 로고
    • Central-Airway necrosis after stereotactic body-radiation therapy
    • Corradetti MN, Haas AR, Rengan R, Central-Airway necrosis after stereotactic body-radiation therapy. N Engl J Med 2012 366 2327 2329
    • (2012) N Engl J Med , vol.366 , pp. 2327-2329
    • Corradetti, M.N.1    Haas, A.R.2    Rengan, R.3
  • 28
    • 4844229902 scopus 로고    scopus 로고
    • Stereotactic hypofractionated high-dose irradiation for stage i nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study
    • Onishi H, Araki T, Shirato H, Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004 101 1623 1631
    • (2004) Cancer , vol.101 , pp. 1623-1631
    • Onishi, H.1    Araki, T.2    Shirato, H.3
  • 29
    • 84903741123 scopus 로고    scopus 로고
    • Vagal and recurrent laryngeal neuropathy following stereotactic ablative radiation therapy in the chest
    • Shultz DB, Trakul N, Maxim PG, Diehn M, Loo BW Jr, Vagal and recurrent laryngeal neuropathy following stereotactic ablative radiation therapy in the chest. Pract Radiat Oncol 2014 4 272 278
    • (2014) Pract Radiat Oncol , vol.4 , pp. 272-278
    • Shultz, D.B.1    Trakul, N.2    Maxim, P.G.3    Diehn, M.4    Loo, B.W.5
  • 30
    • 79959354484 scopus 로고    scopus 로고
    • Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage i non-small-cell lung cancer
    • Register SP, Zhang X, Mohan R, Chang JY, Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2011 80 1015 1022
    • (2011) Int J Radiat Oncol Biol Phys , vol.80 , pp. 1015-1022
    • Register, S.P.1    Zhang, X.2    Mohan, R.3    Chang, J.Y.4
  • 31
    • 84880020196 scopus 로고    scopus 로고
    • High-dose hypofractionated proton beam radiation therapy is safe and effective for central and peripheral early-stage non-small cell lung cancer: Results of a 12-year experience at loma linda university medical center
    • Bush DA, Cheek G, Zaheer S, High-dose hypofractionated proton beam radiation therapy is safe and effective for central and peripheral early-stage non-small cell lung cancer: Results of a 12-year experience at Loma Linda University Medical Center. Int J Radiat Oncol Biol Phys 2013 86 964 968
    • (2013) Int J Radiat Oncol Biol Phys , vol.86 , pp. 964-968
    • Bush, D.A.1    Cheek, G.2    Zaheer, S.3
  • 32
    • 84908157120 scopus 로고    scopus 로고
    • Clinical implementation of intensity-modulated proton therapy for thoracic malignancies
    • Chang JY, Li H, Zhu XR, Clinical implementation of intensity-modulated proton therapy for thoracic malignancies. Int J Radiat Oncol Biol Phys 2014 90 809 818
    • (2014) Int J Radiat Oncol Biol Phys , vol.90 , pp. 809-818
    • Chang, J.Y.1    Li, H.2    Zhu, X.R.3
  • 33
    • 84863634359 scopus 로고    scopus 로고
    • Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer
    • Zhang X, Liu H, Balter P, Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2012 83 1558 1565
    • (2012) Int J Radiat Oncol Biol Phys , vol.83 , pp. 1558-1565
    • Zhang, X.1    Liu, H.2    Balter, P.3
  • 34
    • 84900518391 scopus 로고    scopus 로고
    • New techniques for assessing response after hypofractionated radiotherapy for lung cancer
    • Mattonen SA, Huang K, Ward AD, Senan S, Palma DA, New techniques for assessing response after hypofractionated radiotherapy for lung cancer. J Thorac Dis 2014 6 375 386
    • (2014) J Thorac Dis , vol.6 , pp. 375-386
    • Mattonen, S.A.1    Huang, K.2    Ward, A.D.3    Senan, S.4    Palma, D.A.5
  • 35
    • 84896771547 scopus 로고    scopus 로고
    • Early prediction of tumor recurrence based on ct texture changes after stereotactic ablative radiotherapy (sabr) for lung cancer
    • Mattonen SA, Palma DA, Haasbeek CJ, Senan S, Ward AD, Early prediction of tumor recurrence based on CT texture changes after stereotactic ablative radiotherapy (SABR) for lung cancer. Med Phys 2014 41 033502
    • (2014) Med Phys , vol.41 , pp. 033502
    • Mattonen, S.A.1    Palma, D.A.2    Haasbeek, C.J.3    Senan, S.4    Ward, A.D.5
  • 36
    • 84864342085 scopus 로고    scopus 로고
    • Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: A retrospective analysis
    • Senthi S, Lagerwaard FJ, Haasbeek CJ, Slotman BJ, Senan S, Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: A retrospective analysis. Lancet Oncol 2012 13 802 809
    • (2012) Lancet Oncol , vol.13 , pp. 802-809
    • Senthi, S.1    Lagerwaard, F.J.2    Haasbeek, C.J.3    Slotman, B.J.4    Senan, S.5
  • 37
    • 84905917552 scopus 로고    scopus 로고
    • Incidental prophylactic nodal irradiation and patterns of nodal relapse in inoperable early stage NSCLC patients treated with sbrt: A case-matched analysis
    • Lao L, Hope AJ, Maganti M, Incidental prophylactic nodal irradiation and patterns of nodal relapse in inoperable early stage NSCLC patients treated with SBRT: A case-matched analysis. Int J Radiat Oncol Biol Phys 2014 90 209 215
    • (2014) Int J Radiat Oncol Biol Phys , vol.90 , pp. 209-215
    • Lao, L.1    Hope, A.J.2    Maganti, M.3
  • 38
    • 67649359533 scopus 로고    scopus 로고
    • Systemic effects of local radiotherapy
    • Formenti SC, Demaria S, Systemic effects of local radiotherapy. Lancet Oncol 2009 10 718 726
    • (2009) Lancet Oncol , vol.10 , pp. 718-726
    • Formenti, S.C.1    Demaria, S.2
  • 39
    • 84890043404 scopus 로고    scopus 로고
    • Immune modulation and stereotactic radiation: Improving local and abscopal responses
    • Zeng J, Harris TJ, Lim M, Drake CG, Tran PT, Immune modulation and stereotactic radiation: Improving local and abscopal responses. Biomed Res Int 2013 2013 658126
    • (2013) Biomed Res Int , vol.2013 , pp. 658126
    • Zeng, J.1    Harris, T.J.2    Lim, M.3    Drake, C.G.4    Tran, P.T.5
  • 40
    • 84880093055 scopus 로고    scopus 로고
    • Radiation as an immunological adjuvant: Current evidence on dose and fractionation
    • Demaria S, Formenti SC, Radiation as an immunological adjuvant: Current evidence on dose and fractionation. Front Oncol 2012 2 153
    • (2012) Front Oncol , vol.2 , pp. 153
    • Demaria, S.1    Formenti, S.C.2
  • 41
    • 84863911486 scopus 로고    scopus 로고
    • Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage iiib/IV non-small-cell lung cancer: Results from a randomized, double-blind, multicenter phase II study
    • Lynch TJ, Bondarenko I, Luft A, Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: Results from a randomized, double-blind, multicenter phase II study. J Clin Oncol 2012 30 2046 2054
    • (2012) J Clin Oncol , vol.30 , pp. 2046-2054
    • Lynch, T.J.1    Bondarenko, I.2    Luft, A.3
  • 42
    • 84862859820 scopus 로고    scopus 로고
    • Safety, activity, and immune correlates of anti-pd-1 antibody in cancer
    • Topalian SL, Hodi FS, Brahmer JR, Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012 366 2443 2454
    • (2012) N Engl J Med , vol.366 , pp. 2443-2454
    • Topalian, S.L.1    Hodi, F.S.2    Brahmer, J.R.3
  • 43
    • 84862903106 scopus 로고    scopus 로고
    • Safety and activity of anti-pd-l1 antibody in patients with advanced cancer
    • Brahmer JR, Tykodi SS, Chow LQ, Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 2012 366 2455 2465
    • (2012) N Engl J Med , vol.366 , pp. 2455-2465
    • Brahmer, J.R.1    Tykodi, S.S.2    Chow, L.Q.3
  • 44
    • 84891373760 scopus 로고    scopus 로고
    • Tecemotide (l-blp25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (start): A randomised, double-blind, phase 3 trial
    • START trial team
    • Butts C, Socinski MA, Mitchell PL, START trial team Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): A randomised, double-blind, phase 3 trial. Lancet Oncol 2014 15 59 68
    • (2014) Lancet Oncol , vol.15 , pp. 59-68
    • Butts, C.1    Socinski, M.A.2    Mitchell, P.L.3
  • 45
    • 33750586798 scopus 로고    scopus 로고
    • Phase II study of belagenpumatucel-l, a transforming growth factor 2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer
    • Butts C, Murray N, Maksymiuk A, Phase II study of belagenpumatucel-L, a transforming growth factor 2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer. J Clin Oncol 2006 24 4721 4730
    • (2006) J Clin Oncol , vol.24 , pp. 4721-4730
    • Butts, C.1    Murray, N.2    Maksymiuk, A.3
  • 46
    • 84857815877 scopus 로고    scopus 로고
    • Immunologic correlates of the abscopal effect in a patient with melanoma
    • Postow MA, Callahan MK, Barker CA, Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med 2012 366 925 931
    • (2012) N Engl J Med , vol.366 , pp. 925-931
    • Postow, M.A.1    Callahan, M.K.2    Barker, C.A.3
  • 47
    • 84862124594 scopus 로고    scopus 로고
    • Phase 1 study of stereotactic body radiotherapy and interleukin-2-Tumor and immunological responses
    • Seung SK, Curti BD, Crittenden M, Phase 1 study of stereotactic body radiotherapy and interleukin-2-Tumor and immunological responses. Sci Transl Med 2012 4 137ra74
    • (2012) Sci Transl Med , vol.4 , pp. 137ra74
    • Seung, S.K.1    Curti, B.D.2    Crittenden, M.3
  • 48
    • 84871354890 scopus 로고    scopus 로고
    • Efficacy study of cyberknife stereotactic radiosurgery combined with cik cell immunotherapy for advanced refractory lung cancer
    • Wang YY, Wang YS, Liu T, Efficacy study of CyberKnife stereotactic radiosurgery combined with CIK cell immunotherapy for advanced refractory lung cancer. Exp Ther Med 2013 5 453 456
    • (2013) Exp Ther Med , vol.5 , pp. 453-456
    • Wang, Y.Y.1    Wang, Y.S.2    Liu, T.3
  • 49
    • 84888047493 scopus 로고    scopus 로고
    • 18f-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic body radiation therapy
    • 18F-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic body radiation therapy. Radiother Oncol 2013 109 82 88
    • (2013) Radiother Oncol , vol.109 , pp. 82-88
    • Evans, J.D.1    Gomez, D.R.2    Chang, J.Y.3
  • 50
    • 79961128999 scopus 로고    scopus 로고
    • Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy
    • Welsh J, Thomas J, Shah D, Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2011 81 91 96
    • (2011) Int J Radiat Oncol Biol Phys , vol.81 , pp. 91-96
    • Welsh, J.1    Thomas, J.2    Shah, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.